State Street’s DNA X Inc SONM Stock Holding History

State Street’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-237	Closed	-$42.7K	–	4335
2024 Q2	$42.7K	Hold	237	–	–	﹤0.01%	4167
2024 Q1	$26K	Hold	237	–	–	﹤0.01%	4259
2023 Q4	$31.4K	Hold	237	–	–	﹤0.01%	4276
2023 Q3	$28.9K	Buy	237 +107	+82%	+$14.9K	﹤0.01%	4388
2023 Q2	$26.9K	Hold	130	–	–	﹤0.01%	4552
2023 Q1	$23.6K	Hold	130	–	–	﹤0.01%	4661
2022 Q4	$9.94K	Hold	130	–	–	﹤0.01%	4806
2022 Q3	$12K	Buy	+130	New	+$16.1K	﹤0.01%	4883
2021 Q3	–	Sell	-40	Closed	-$40K	–	4702
2021 Q2	$40K	Buy	+40	New	+$43.5K	﹤0.01%	4445
2020 Q2	–	Sell	-48	Closed	-$60K	–	3853
2020 Q1	$60K	Buy	48 +19	+66%	+$91K	﹤0.01%	3647
2019 Q4	$192K	Buy	29 +11	+61%	+$54.3K	﹤0.01%	3641
2019 Q3	$97K	Sell	18 -1	-5%	-$15.3K	﹤0.01%	3669
2019 Q2	$299K	Buy	+19	New	+$482K	﹤0.01%	3572

Other funds holding SONM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

State Street's SONM Position: Q3 2024 in Review

State Street sold out of DNA X Inc (SONM) in Q3 2024, closing a stake of 237 shares — an estimated $42.7K sold.

State Street first reported a position in SONM in Q2 2019 and held it in 13 quarters. The position peaked at $299K in Q2 2019. 8 funds tracked by Wall St. Rank hold SONM as of Q3 2024.

State Street reported no remaining DNA X Inc position as of Q3 2024 after selling out during the quarter.
State Street sold 237 DNA X Inc shares in Q3 2024, an estimated $42.7K.
State Street first reported a position in DNA X Inc in Q2 2019 and held it in 13 quarters.
State Street's DNA X Inc position peaked at $299K in Q2 2019.
8 funds tracked by Wall St. Rank held DNA X Inc as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.